FLAIR and Diffusion MRI Signals Are Independent Predictors of White Matter Hyperintensities

References

1. 1.↵
   1. DeCarli C,
   2. Murphy DG,
   3. Tranh M,
   4. et al

   . The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults. Neurology 1995;45:2077–84

   CrossRef
2. 2.↵
   1. O'Brien J,
   2. Desmond P,
   3. Ames D,
   4. et al

   . A magnetic resonance imaging study of white matter lesions in depression and Alzheimer's disease. Br J Psychiatry 1996;168:477–85

   Abstract/FREE Full Text
3. 3.↵
   1. Buckner RL

   . Memory and executive function in aging and AD: multiple factors that cause decline and reserve factors that compensate. Neuron 2004;44:195–208

   CrossRefPubMedWeb of Science
4. 4.↵
   1. DeCarli C,
   2. Miller BL,
   3. Swan GE,
   4. et al

   . Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. Arch Neurol 2001;58:643–47

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Nordahl CW,
   2. Ranganath C,
   3. Yonelinas AP,
   4. et al

   . White matter changes compromise prefrontal cortex function in healthy elderly individuals. J Cogn Neurosci 2006;18:418–29

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Nordahl CW,
   2. Ranganath C,
   3. Yonelinas AP,
   4. et al

   . Different mechanisms of episodic memory failure in mild cognitive impairment. Neuropsychologia 2005;43:1688–97

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Yoshita M,
   2. Fletcher E,
   3. Harvey D,
   4. et al

   . Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD. Neurology 2006;67:2192–98

   CrossRef
8. 8.↵
   1. Lee DY,
   2. Fletcher E,
   3. Martinez O,
   4. et al

   . Regional pattern of white matter microstructural changes in normal aging, MCI, and AD. Neurology 2009;73:1722–28

   CrossRef
9. 9.↵
   1. Charlton RA,
   2. Barrick TR,
   3. McIntyre DJ,
   4. et al

   . White matter damage on diffusion tensor imaging correlates with age-related cognitive decline. Neurology 2006;66:217–22

   CrossRef
10. 10.↵
    1. Charlton RA,
    2. Schiavone F,
    3. Barrick TR,
    4. et al

    . Diffusion tensor imaging detects age related white matter change over a 2 year follow-up which is associated with working memory decline. J Neurol Neurosurg Psychiatry 2010;81:13–19

    Abstract/FREE Full Text
11. 11.↵
    1. Au R,
    2. Massaro JM,
    3. Wolf PA,
    4. et al

    . Association of white matter hyperintensity volume with decreased cognitive functioning: the Framingham Heart Study. Arch Neurol 2006;63:246–50

    CrossRefPubMedWeb of Science
12. 12.↵
    1. van Straaten EC,
    2. Harvey D,
    3. Scheltens P,
    4. et al

    . Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementia. J Neurol 2008;255:1302–08

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Debette S,
    2. Seshadri S,
    3. Beiser A,
    4. et al

    . Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology 2011;77:461–68

    CrossRef
14. 14.↵
    1. Debette S,
    2. Beiser A,
    3. Decarli C,
    4. et al

    . Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study. Stroke 2010;41:600–06

    Abstract/FREE Full Text
15. 15.↵
    1. Neal B,
    2. MacMahon S

    . PROGRESS (Perindopril Protection Against Recurrent Stroke Study): rationale and design—PROGRESS Management Committee [corrected]. J Hypertens 1995;13(12 pt 2):1869–73

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Tzourio C,
    2. Anderson C

    . Blood pressure reduction and risk of dementia in patients with stroke: rationale of the dementia assessment in PROGRESS (Perindopril Protection Against Recurrent Stroke Study)—PROGRESS Management Committee. J Hypertens Suppl 2000;18:S21–24

    PubMed
17. 17.↵
    1. Maillard P,
    2. Fletcher E,
    3. Harvey D,
    4. et al

    . White matter hyperintensity penumbra. Stroke 2011;42:1917–22

    Abstract/FREE Full Text
18. 18.↵
    1. Wen W,
    2. Sachdev P

    . The topography of white matter hyperintensities on brain MRI in healthy 60- to 64-year-old individuals. Neuroimage 2004;22:144–54

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Lee DY,
    2. Fletcher E,
    3. Martinez O,
    4. et al

    . Vascular and degenerative processes differentially affect regional interhemispheric connections in normal aging, mild cognitive impairment, and Alzheimer disease. Stroke 2010;41:1791–97

    Abstract/FREE Full Text
20. 20.↵
    1. Sullivan E,
    2. Pfefferbaum A

    . Diffusion tensor imaging and aging. Neurosci Biobehav Rev 2006;30:749–61

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Teipel SJ,
    2. Meindl T,
    3. Wagner M,
    4. et al

    . Longitudinal changes in fiber tract integrity in healthy aging and mild cognitive impairment: a DTI follow-up study. J Alzheimers Dis 2010;22:507–22

    PubMedWeb of Science
22. 22.↵
    1. Sullivan EV,
    2. Rohlfing T,
    3. Pfefferbaum A

    . Longitudinal study of callosal microstructure in the normal adult aging brain using quantitative DTI fiber tracking. Dev Neuropsychol 2010;35:233–56

    CrossRefPubMed
23. 23.↵
    1. Cheng YW,
    2. Chung HW,
    3. Chen CY,
    4. et al

    . Diffusion tensor imaging with cerebrospinal fluid suppression and signal-to-noise preservation using acquisition combining fluid-attenuated inversion recovery and conventional imaging: comparison of fiber tracking. Eur J Radiol 2010;79:113–17

    PubMed
24. 24.↵
    1. McKhann G,
    2. Drachman D,
    3. Folstein M,
    4. et al

    . Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939–44

    CrossRef
25. 25.↵
    1. Winblad B,
    2. Palmer K,
    3. Kivipelto M,
    4. et al

    . Mild cognitive impairment: beyond controversies, towards a consensus—report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004;256:240–46

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Carmichael O,
    2. Mungas D,
    3. Beckett L,
    4. et al

    . MRI predictors of cognitive change in a diverse and carefully characterized elderly population. Neurobiol Aging 2010;33:83–95

    PubMed
27. 27.↵
    1. Haselgrove JC,
    2. Moore JR

    . Correction for distortion of echo-planar images used to calculate the apparent diffusion coefficient. Magn Reson Med 1996;36:960–64

    PubMedWeb of Science
28. 28.↵
    1. DeCarli C,
    2. Fletcher E,
    3. Ramey V,
    4. et al

    . Anatomical mapping of white matter hyperintensities (WMH): exploring the relationships between periventricular WMH, deep WMH, and total WMH burden. Stroke 2005;36:50–55

    Abstract/FREE Full Text
29. 29.↵
    1. Kochunov P,
    2. Lancaster JL,
    3. Thompson P,
    4. et al

    . Regional spatial normalization: toward an optimal target. J Comput Assist Tomogr 2001;25:805–16

    CrossRefPubMedWeb of Science
30. 30.↵
    1. Rajapakse JC,
    2. DeCarli C,
    3. McLaughlin A,
    4. et al

    . Cerebral magnetic resonance image segmentation using data fusion. J Comput Assist Tomogr 1996;20:206–18

    CrossRefPubMed
31. 31.↵
    1. Gouw AA,
    2. van der Flier WM,
    3. Fazekas F,
    4. et al

    . Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability Study. Stroke 2008;39:1414–20

    Abstract/FREE Full Text
32. 32.↵
    1. Nitkunan A,
    2. Barrick TR,
    3. Charlton RA,
    4. et al

    . Multimodal MRI in cerebral small vessel disease: its relationship with cognition and sensitivity to change over time. Stroke 2008;39:1999–2005

    Abstract/FREE Full Text
33. 33.↵
    1. Bronge L

    . Magnetic resonance imaging in dementia: a study of brain white matter changes. Acta Radiol Suppl 2002:1–32
34. 34.↵
    1. Sachdev P,
    2. Wen W,
    3. Shnier R,
    4. et al

    . Cerebral blood volume in T2-weighted white matter hyperintensities using exogenous contrast based perfusion MRI. J Neuropsychiatry Clin Neurosci 2004;16:83–92

    PubMed
35. 35.↵
    1. Hashemi RH,
    2. Bradley WG,
    3. Lisanti CJ

    . MRI: The Basics. Philadelphia: Lippincott Williams & Wilkins; 2010
36. 36.↵
    1. Kim K,
    2. Macfall J,
    3. Payne M

    . Classification of white matter lesions on magnetic resonance imaging in elderly persons. Biol Psychiatry 2008;64:273–80

    CrossRefPubMed
37. 37.↵
    1. Godin O,
    2. Tzourio C,
    3. Maillard P,
    4. et al

    . Antihypertensive treatment and change in blood pressure are associated with the progression of white matter lesion volumes: the Three-City (3C)-Dijon Magnetic Resonance Imaging Study. Circulation 2011;123:266–73

    Abstract/FREE Full Text
38. 38.↵
    1. Schmidt R,
    2. Grazer A,
    3. Enzinger C,
    4. et al

    . MRI-detected white matter lesions: do they really matter? J Neural Transm 2011;118:673–81

    CrossRefPubMed
39. 39.↵
    1. Xu H,
    2. Stamova B,
    3. Jickling G,
    4. et al

    . Distinctive RNA expression profiles in blood associated with white matter hyperintensities in brain. Stroke 2010;41:2744–49

    Abstract/FREE Full Text
40. 40.↵
    1. Aggarwal NT,
    2. Wilson RS,
    3. Bienias JL,
    4. et al

    . The association of magnetic resonance imaging measures with cognitive function in a biracial population sample. Arch Neurol 2010;67:475–82

    CrossRefPubMedWeb of Science